Developing quantum-sensor heart scanners to assess coronary artery disease
Coronary artery disease reduces blood supply to the heart and can lead to a heart attack. Assessing its effect on heart function often requires specialist diagnostic equipment and trained staff. Faster, accessible examinations could help clinicians identify patients who need further investigation.
MatterDecoder is developing a compact heart scanner to help doctors assess coronary artery disease in minutes. Its radiation-free examination is designed to make functional heart assessment more accessible and support earlier clinical decisions.
What stands out about MatterDecoder
MatterDecoder joined FHNW, CSEM and University Hospital Basel in an Innosuisse-backed project developing compact cardiac quantum sensing.
Founder Clément Javerzac previously co-founded Miraex, developing photonic sensing and computing hardware based on semiconductor processes.
Clément Javerzac led FHNW’s applied quantum computing group, created to bring quantum methods into life-science research and education.
FHNW identifies MatterDecoder as a spin-off; CSEM also describes it as FHNW’s startup in their cardiac quantum-sensing collaboration.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.